Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD
Brazilian researchers say that "CBD-rich extracts seem to present a better therapeutic profile than purified CBD"
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• October 5, 2018
Cannabis-based epilepsy treatment Epidiolex will cost $32,500 annually
The expensive price tag means that the parents of children with Lennox syndrome and Dravet syndrome may search for cheaper CBD-based treatments elsewhere
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 29, 2018
Great Britain prepares to legalize cannabis for medicinal use
The Advisory Council on the Misuse of Drugs (ACMD) wants doctors to prescribe medicinal cannabis medicines that have been developed in accordance with safety standards.
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 3, 2018
CEO of GW Pharma talks about Epidiolex getting FDA approval
The DEA must accurately categorize CBD within 90 days of the approval
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 2, 2018
Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 3, 2018
FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• April 19, 2018
Load More Stories